"Neurotransmitter Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Substances used for their pharmacological actions on any aspect of neurotransmitter systems. Neurotransmitter agents include agonists, antagonists, degradation inhibitors, uptake inhibitors, depleters, precursors, and modulators of receptor function.
Descriptor ID |
D018377
|
MeSH Number(s) |
D27.505.519.625 D27.505.696.577
|
Concept/Terms |
Neurotransmitters- Neurotransmitters
- Transmitter Substances, Nerve
- Substances, Nerve Transmitter
- Nerve Transmitter Substances
- Neurotransmitter
|
Below are MeSH descriptors whose meaning is more general than "Neurotransmitter Agents".
Below are MeSH descriptors whose meaning is more specific than "Neurotransmitter Agents".
This graph shows the total number of publications written about "Neurotransmitter Agents" by people in this website by year, and whether "Neurotransmitter Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1995 | 1 | 0 | 1 |
2016 | 1 | 0 | 1 |
2017 | 4 | 7 | 11 |
2018 | 6 | 5 | 11 |
2019 | 4 | 1 | 5 |
2020 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Neurotransmitter Agents" by people in Profiles.
-
Covid-19 interface with drug misuse and substance use disorders. Neuropharmacology. 2021 10 15; 198:108766.
-
Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cells. Neuropeptides. 2021 Oct; 89:102159.
-
T Cells Plead for Rejuvenation and Amplification; With the Brain's Neurotransmitters and Neuropeptides We Can Make It Happen. Front Immunol. 2021; 12:617658.
-
Hypothetical dysfunction of the epithelial sodium channel may justify neurohumoral blockade in coronavirus disease 2019. ESC Heart Fail. 2021 02; 8(1):171-174.
-
Potential Neurochemical and Neuroendocrine Effects of Social Distancing Amidst the COVID-19 Pandemic. Front Endocrinol (Lausanne). 2020; 11:582288.
-
Towards a pharmacochemical hypothesis of the prophylaxis of SARS-CoV-2 by psychoactive substances. Med Hypotheses. 2020 Nov; 144:110025.
-
Brexpiprazole as an augmentation agent to antidepressants in treatment resistant major depressive disorder. Expert Rev Neurother. 2019 09; 19(9):777-783.
-
Migraine and cluster headache show impaired neurosteroids patterns. J Headache Pain. 2019 May 27; 20(1):61.
-
Cross-Talk between Neurohormonal Pathways and the Immune System in Heart Failure: A Review of the Literature. Int J Mol Sci. 2019 Apr 05; 20(7).
-
Glutamatergic Signaling Along The Microbiota-Gut-Brain Axis. Int J Mol Sci. 2019 Mar 25; 20(6).